This move is archived. Current quotes and coverage live on the stock page.
Follow CNVI
Conavi Medical Corp. faces a significant drop in stock value, raising concerns among investors.
Conavi Medical Corp. (CNVI.V) saw its stock price fall sharply today, dropping 5.26% to close at CA$0.18. This decline comes amid limited news and market activity, leaving investors uncertain about the company's future prospects.
Investor takeaway: Investors should be cautious, as today’s drop in Conavi Medical’s stock highlights potential vulnerabilities in its market position and operational performance.
Advertisement
Conavi Medical Corp.
CNVI.V
CNVI.V
Conavi Medical Corp.
WealthAwesomeMarket cap
$20.01M
52W high
$0.70
52W low
$0.14
1W change
-9.38%
Analyst Price Targets
Based on analyst covering CNVI · as of Sep 30, 2026
Wall Street analysts forecast CNVI stock price to rise 796.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$1.30
+796.6% Upside
Previously C$1.00 on Sep 17, 2026
Current Price
C$0.14
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CNVI's historical volatility
30-Day Vol
67.8%
Annualized
90-Day Vol
91.6%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.12
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.14 | C$0.11 – C$0.17 |
| 60 trading days | C$0.13 | C$0.09 – C$0.18 |
| 90 trading days | C$0.12 | C$0.08 – C$0.18 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Conavi Medical Corp. stock falls 5.26% today
With a market cap of approximately CA$20.7 million, the company’s stock performance is under scrutiny as it navigates a challenging market environment.
Bull case
Despite the current downturn, Conavi Medical has made progress in product development. Notably, it has submitted its Novasight Hybrid™ system to the U.S. FDA, which could pave the way for future growth.
Bear case
However, the lack of recent positive news and today’s significant drop may signal deeper issues within the company. This could affect investor confidence and future performance.
Market Reaction
Advertisement
Conavi Medical’s stock decline today reflects a broader market sentiment influenced by the company’s recent performance and absence of significant news. Investors are likely reassessing their positions as they react to the stock’s volatility.
Future Outlook
While Conavi Medical has made strides in product development, the current dip raises questions about its ability to maintain investor confidence. Stakeholders will be closely monitoring upcoming announcements and financial results to gauge the company’s trajectory.
Investor Sentiment
Today’s drop in Conavi Medical’s stock price suggests a shift in investor sentiment. With no major news to counterbalance the decline, market participants may be wary of potential risks, especially regarding the company’s ongoing efforts to penetrate the U.S. market.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
